LLY P/E Ratio
Share price divided by earnings per share — what investors pay for each dollar of profit.
P/E Ratio
Latest: 40.2 (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | 114.2 |
| 2024Q2 | 111.0 |
| 2024Q3 | 95.3 |
| 2024Q4 | 65.6 |
| 2025Q1 | 66.8 |
| 2025Q2 | 50.7 |
| 2025Q3 | 37.2 |
| 2025Q4 | 46.6 |
| 2026Q1 | 32.7 |
| 2026Q2 | 40.2 |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest P/E Ratio: 40.2 (2026Q2); -20.6% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, P/E Ratio ranged from 32.7 in 2026Q1 to 114.2 in 2024Q1.